Sens. Orrin Hatch (R-Utah), Chuck Grassley (R-Iowa) and Tom Cotton (R-Arkansas.) raised the possibility that regulatory or legislative changes might be needed “to preserve the intent of this vital law” that gives drugmakers lucrative incentives to develop drugs for rare diseases.
Senate Finance Committee Chairman Sen. Orrin Hatch (R-Utah) suspended rules requiring a quorum for a vote, allowing Price to advance to the full Senate.
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
Senate Finance Committee ranking member Ron Wyden (D-Oregon) was rather relentless in questioning Price.
Andy Slavitt, who has served as acting administrator of the Centers for Medicare and Medicaid Services since the beginning of March, has been nominated to be permanent head of the agency. Already, some key Republicans have expressed concern because of Slavitt's ties to the troubled HealthCare.gov insurance marketplace, a symbol of GOP opposition to the Affordable Care Act.
After Sen. Richard Burr (R-N.C.), Sen. Orrin Hatch (R-Utah) and Rep. Fred Upton (R-Mich.) unveiled a draft of an Obamacare replacement plan on Wednesday, Burr acknowledged on Thursday that it will still take time for consensus to be met and an alternative might not pass until 2017. Burr appeared on Fox News’ “Special Report with […]
Legislation was approved unanimously by the Senate Finance Committee Wednesday to exclude veterans from the Obamacare employer mandate. The legislation allows veteran workers, who receive health coverage from the Defense Department or the Department of Veterans Affairs, to not be included by companies in the count for employer mandate purposes. “The Hire More Heroes Act […]
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.